Financial Toxicity and Out-of-Pocket Costs for Patients with Head and Neck Cancer
Current Oncology · 10.05.2023 · 30 (5) · 4922-4935
DOI: 10.3390/curroncol30050371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 10.05.2023. Verfasst von Justin Smith und 3 weiteren Autor:innen. Beteiligte Einrichtung: Townsville University Hospital, Townsville, QLD 4814, Australia. Hauptthemen laut MEDLINE: Quality of Life, Head and Neck Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Townsville Hospital and Health Service Study, Education and Research Trust Account (SERTA).
Abstract (Originalsprache)
Aim
To quantify financial toxicity and out-of-pocket costs for patients with HNC in Australia and explore their relationship with health-related quality of life (HRQoL).
Methods
A cross-sectional survey was administered to patients with HNC 1–3 years after radiotherapy at a regional hospital in Australia. The survey included questions on sociodemographics, out-of-pocket expenses, HRQoL, and the Financial Index of Toxicity (FIT) tool. The relationship between high financial toxicity scores (top quartile) and HRQoL was explored.
Results
Of the 57 participants included in the study, 41 (72%) reported out-of-pocket expenses at a median of AUD 1796 (IQR AUD 2700) and a maximum of AUD 25,050. The median FIT score was 13.9 (IQR 19.5) and patients with high financial toxicity (n = 14) reported poorer HRQoL (76.5 vs. 114.5, p < 0.001). Patients who were not married had higher FIT scores (23.1 vs. 11.1, p = 0.01), as did those with lower education (19.3 vs. 11.1, p = 0.06). Participants with private health insurance had lower financial toxicity scores (8.3 vs. 17.6, p = 0.01). Medications (41%, median AUD 400), dietary supplements (41%, median AUD 600), travel (36%, median AUD 525), and dental (29%, AUD 388) were the most common out-of-pocket expenses. Participants living in rural locations (≥100 km from the hospital) had higher out-of-pocket expenses (AUD 2655 vs. AUD 730, p = 0.01).
Conclusion
Financial toxicity is associated with poorer HRQoL for many patients with HNC following treatment. Further research is needed to investigate interventions aimed at reducing financial toxicity and how these can best be incorporated into routine clinical care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Townsville University Hospital, Townsville, QLD 4814, Australia.
- College of Medicine and Dentistry, James Cook University, Townsville, QLD 4811, Australia.
- Health Economics, Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
- School of Public Health, The University of Queensland, Brisbane, QLD 4006, Australia.
- School of Nursing, Queensland University of Technology, Brisbane, QLD 4059, Australia.
ORCID-Profile: Justin Smith, Justin Yu, Louisa G Gordon
Förderung
- Townsville Hospital and Health Service Study, Education and Research Trust Account (SERTA)
Zitieren
APA
Smith, J., Yu, J., Gordon, L. G., & Chilkuri, M. (2023). Financial Toxicity and Out-of-Pocket Costs for Patients with Head and Neck Cancer. Current Oncology, 30(5), 4922-4935. https://doi.org/10.3390/curroncol30050371
Vancouver
Smith J, Yu J, Gordon LG, Chilkuri M. Financial Toxicity and Out-of-Pocket Costs for Patients with Head and Neck Cancer. Current Oncology. 2023;30(5):4922-4935. doi:10.3390/curroncol30050371
BibTeX
@article{Smith2023,
author = {Smith, Justin and Yu, Justin and Gordon, Louisa G and Chilkuri, Madhavi},
title = {Financial Toxicity and Out-of-Pocket Costs for Patients with Head and Neck Cancer},
journal = {Current Oncology},
year = {2023},
volume = {30},
number = {5},
pages = {4922--4935},
doi = {10.3390/curroncol30050371}
}
EUVIMED